Drug Type Small molecule drug |
Synonyms Antibiotic 89-07, Etimicin, E-402 + [6] |
Target |
Action inhibitors |
Mechanism 30S subunit inhibitors(30S ribosomal subunit inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date China (01 Jan 1999), |
Regulation- |
Molecular FormulaC21H45N5O11S |
InChIKeyOEBISAUVQBGQKC-ZIZSAZPJSA-N |
CAS Registry362045-44-1 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Bacterial Infections | China | 01 Jan 1999 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Bronchiectasis | Phase 1 | China | 01 Jul 2024 | |
| Bronchiectasis | Phase 1 | China | 01 Jul 2024 | |
| Pseudomonas aeruginosa infection | Phase 1 | China | 01 Jul 2024 | |
| Pseudomonas aeruginosa infection | Phase 1 | China | 01 Jul 2024 |





